nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—ALB—multiple sclerosis	0.232	1	CbGaD
Losartan—SLCO1B3—Methotrexate—multiple sclerosis	0.0525	0.113	CbGbCtD
Losartan—ALB—Prednisone—multiple sclerosis	0.0334	0.0717	CbGbCtD
Losartan—SLCO1B1—Methotrexate—multiple sclerosis	0.0306	0.0657	CbGbCtD
Losartan—ABCB1—Methylprednisolone—multiple sclerosis	0.0288	0.0619	CbGbCtD
Losartan—CYP3A4—Fingolimod—multiple sclerosis	0.0268	0.0576	CbGbCtD
Losartan—CYP2C19—Prednisone—multiple sclerosis	0.0216	0.0465	CbGbCtD
Losartan—ABCB1—Mitoxantrone—multiple sclerosis	0.021	0.0452	CbGbCtD
Losartan—SLC22A6—Methotrexate—multiple sclerosis	0.0197	0.0423	CbGbCtD
Losartan—ABCB1—Betamethasone—multiple sclerosis	0.0187	0.0403	CbGbCtD
Losartan—ABCB1—Prednisolone—multiple sclerosis	0.0185	0.0397	CbGbCtD
Losartan—ABCB1—Prednisone—multiple sclerosis	0.0175	0.0375	CbGbCtD
Losartan—CYP3A4—Methylprednisolone—multiple sclerosis	0.0173	0.0371	CbGbCtD
Losartan—CYP3A5—Dexamethasone—multiple sclerosis	0.0167	0.036	CbGbCtD
Losartan—ALB—Methotrexate—multiple sclerosis	0.0167	0.036	CbGbCtD
Losartan—CYP2C8—Dexamethasone—multiple sclerosis	0.0161	0.0346	CbGbCtD
Losartan—CYP2C19—Dexamethasone—multiple sclerosis	0.0135	0.029	CbGbCtD
Losartan—CYP3A4—Triamcinolone—multiple sclerosis	0.0131	0.0281	CbGbCtD
Losartan—CYP3A4—Mitoxantrone—multiple sclerosis	0.0126	0.0271	CbGbCtD
Losartan—CYP2C9—Dexamethasone—multiple sclerosis	0.0112	0.0241	CbGbCtD
Losartan—CYP3A4—Betamethasone—multiple sclerosis	0.0112	0.0241	CbGbCtD
Losartan—CYP3A4—Prednisolone—multiple sclerosis	0.0111	0.0238	CbGbCtD
Losartan—ABCB1—Dexamethasone—multiple sclerosis	0.0109	0.0234	CbGbCtD
Losartan—CYP3A4—Prednisone—multiple sclerosis	0.0105	0.0225	CbGbCtD
Losartan—ABCB1—Methotrexate—multiple sclerosis	0.00876	0.0188	CbGbCtD
Losartan—CYP3A4—Dexamethasone—multiple sclerosis	0.00653	0.014	CbGbCtD
Losartan—Conjunctivitis—Methotrexate—multiple sclerosis	0.000179	0.000913	CcSEcCtD
Losartan—Confusional state—Methylprednisolone—multiple sclerosis	0.000179	0.000912	CcSEcCtD
Losartan—Malaise—Dexamethasone—multiple sclerosis	0.000179	0.000909	CcSEcCtD
Losartan—Malaise—Betamethasone—multiple sclerosis	0.000179	0.000909	CcSEcCtD
Losartan—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000178	0.000907	CcSEcCtD
Losartan—Oedema—Triamcinolone—multiple sclerosis	0.000178	0.000907	CcSEcCtD
Losartan—Vertigo—Dexamethasone—multiple sclerosis	0.000178	0.000906	CcSEcCtD
Losartan—Vertigo—Betamethasone—multiple sclerosis	0.000178	0.000906	CcSEcCtD
Losartan—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000178	0.000905	CcSEcCtD
Losartan—Syncope—Dexamethasone—multiple sclerosis	0.000178	0.000904	CcSEcCtD
Losartan—Syncope—Betamethasone—multiple sclerosis	0.000178	0.000904	CcSEcCtD
Losartan—Arrhythmia—Prednisone—multiple sclerosis	0.000177	0.000901	CcSEcCtD
Losartan—Infection—Triamcinolone—multiple sclerosis	0.000177	0.000901	CcSEcCtD
Losartan—Sweating—Methotrexate—multiple sclerosis	0.000177	0.0009	CcSEcCtD
Losartan—Infection—Methylprednisolone—multiple sclerosis	0.000177	0.000899	CcSEcCtD
Losartan—Shock—Triamcinolone—multiple sclerosis	0.000175	0.000892	CcSEcCtD
Losartan—Insomnia—Prednisolone—multiple sclerosis	0.000175	0.000892	CcSEcCtD
Losartan—Alopecia—Prednisone—multiple sclerosis	0.000175	0.000891	CcSEcCtD
Losartan—Shock—Methylprednisolone—multiple sclerosis	0.000175	0.00089	CcSEcCtD
Losartan—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000174	0.000887	CcSEcCtD
Losartan—Loss of consciousness—Betamethasone—multiple sclerosis	0.000174	0.000886	CcSEcCtD
Losartan—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000174	0.000886	CcSEcCtD
Losartan—Epistaxis—Methotrexate—multiple sclerosis	0.000174	0.000886	CcSEcCtD
Losartan—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000174	0.000886	CcSEcCtD
Losartan—Paraesthesia—Prednisolone—multiple sclerosis	0.000174	0.000886	CcSEcCtD
Losartan—Tachycardia—Triamcinolone—multiple sclerosis	0.000174	0.000885	CcSEcCtD
Losartan—Nausea—Azathioprine—multiple sclerosis	0.000174	0.000883	CcSEcCtD
Losartan—Tachycardia—Methylprednisolone—multiple sclerosis	0.000174	0.000883	CcSEcCtD
Losartan—Erythema—Prednisone—multiple sclerosis	0.000173	0.000878	CcSEcCtD
Losartan—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000172	0.000877	CcSEcCtD
Losartan—Agranulocytosis—Methotrexate—multiple sclerosis	0.000172	0.000876	CcSEcCtD
Losartan—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000172	0.000875	CcSEcCtD
Losartan—Asthenia—Mitoxantrone—multiple sclerosis	0.00017	0.000862	CcSEcCtD
Losartan—Myalgia—Dexamethasone—multiple sclerosis	0.000169	0.000858	CcSEcCtD
Losartan—Myalgia—Betamethasone—multiple sclerosis	0.000169	0.000858	CcSEcCtD
Losartan—Anxiety—Dexamethasone—multiple sclerosis	0.000168	0.000855	CcSEcCtD
Losartan—Anxiety—Betamethasone—multiple sclerosis	0.000168	0.000855	CcSEcCtD
Losartan—Discomfort—Dexamethasone—multiple sclerosis	0.000167	0.000848	CcSEcCtD
Losartan—Discomfort—Betamethasone—multiple sclerosis	0.000167	0.000848	CcSEcCtD
Losartan—Hypotension—Methylprednisolone—multiple sclerosis	0.000166	0.000846	CcSEcCtD
Losartan—Pain—Prednisolone—multiple sclerosis	0.000166	0.000843	CcSEcCtD
Losartan—Hepatitis—Methotrexate—multiple sclerosis	0.000166	0.000843	CcSEcCtD
Losartan—Pharyngitis—Methotrexate—multiple sclerosis	0.000164	0.000837	CcSEcCtD
Losartan—Vision blurred—Prednisone—multiple sclerosis	0.000163	0.000828	CcSEcCtD
Losartan—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000162	0.000826	CcSEcCtD
Losartan—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000162	0.000824	CcSEcCtD
Losartan—Oedema—Dexamethasone—multiple sclerosis	0.000162	0.000823	CcSEcCtD
Losartan—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000162	0.000823	CcSEcCtD
Losartan—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000162	0.000823	CcSEcCtD
Losartan—Oedema—Betamethasone—multiple sclerosis	0.000162	0.000823	CcSEcCtD
Losartan—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000162	0.000822	CcSEcCtD
Losartan—Insomnia—Triamcinolone—multiple sclerosis	0.000161	0.00082	CcSEcCtD
Losartan—Insomnia—Methylprednisolone—multiple sclerosis	0.000161	0.000818	CcSEcCtD
Losartan—Infection—Dexamethasone—multiple sclerosis	0.000161	0.000818	CcSEcCtD
Losartan—Infection—Betamethasone—multiple sclerosis	0.000161	0.000818	CcSEcCtD
Losartan—Ill-defined disorder—Prednisone—multiple sclerosis	0.00016	0.000815	CcSEcCtD
Losartan—Paraesthesia—Triamcinolone—multiple sclerosis	0.00016	0.000814	CcSEcCtD
Losartan—Feeling abnormal—Prednisolone—multiple sclerosis	0.00016	0.000813	CcSEcCtD
Losartan—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00016	0.000813	CcSEcCtD
Losartan—Anaemia—Prednisone—multiple sclerosis	0.00016	0.000812	CcSEcCtD
Losartan—Shock—Dexamethasone—multiple sclerosis	0.000159	0.00081	CcSEcCtD
Losartan—Shock—Betamethasone—multiple sclerosis	0.000159	0.00081	CcSEcCtD
Losartan—Dyspnoea—Triamcinolone—multiple sclerosis	0.000159	0.000809	CcSEcCtD
Losartan—Nervous system disorder—Betamethasone—multiple sclerosis	0.000159	0.000807	CcSEcCtD
Losartan—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000159	0.000807	CcSEcCtD
Losartan—Agitation—Prednisone—multiple sclerosis	0.000159	0.000807	CcSEcCtD
Losartan—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000158	0.000806	CcSEcCtD
Losartan—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000158	0.000806	CcSEcCtD
Losartan—Tachycardia—Dexamethasone—multiple sclerosis	0.000158	0.000803	CcSEcCtD
Losartan—Tachycardia—Betamethasone—multiple sclerosis	0.000158	0.000803	CcSEcCtD
Losartan—Angioedema—Prednisone—multiple sclerosis	0.000158	0.000802	CcSEcCtD
Losartan—Dyspepsia—Triamcinolone—multiple sclerosis	0.000157	0.000798	CcSEcCtD
Losartan—Erythema multiforme—Methotrexate—multiple sclerosis	0.000157	0.000797	CcSEcCtD
Losartan—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000157	0.000797	CcSEcCtD
Losartan—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000156	0.000795	CcSEcCtD
Losartan—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000156	0.000795	CcSEcCtD
Losartan—Malaise—Prednisone—multiple sclerosis	0.000156	0.000792	CcSEcCtD
Losartan—Vertigo—Prednisone—multiple sclerosis	0.000155	0.000789	CcSEcCtD
Losartan—Syncope—Prednisone—multiple sclerosis	0.000155	0.000787	CcSEcCtD
Losartan—Tinnitus—Methotrexate—multiple sclerosis	0.000155	0.000786	CcSEcCtD
Losartan—Anorexia—Betamethasone—multiple sclerosis	0.000154	0.000784	CcSEcCtD
Losartan—Anorexia—Dexamethasone—multiple sclerosis	0.000154	0.000784	CcSEcCtD
Losartan—Urticaria—Prednisolone—multiple sclerosis	0.000154	0.000783	CcSEcCtD
Losartan—Fatigue—Triamcinolone—multiple sclerosis	0.000154	0.000782	CcSEcCtD
Losartan—Fatigue—Methylprednisolone—multiple sclerosis	0.000153	0.00078	CcSEcCtD
Losartan—Pain—Triamcinolone—multiple sclerosis	0.000152	0.000776	CcSEcCtD
Losartan—Loss of consciousness—Prednisone—multiple sclerosis	0.000152	0.000772	CcSEcCtD
Losartan—Hypotension—Dexamethasone—multiple sclerosis	0.000151	0.000769	CcSEcCtD
Losartan—Hypotension—Betamethasone—multiple sclerosis	0.000151	0.000769	CcSEcCtD
Losartan—Angiopathy—Methotrexate—multiple sclerosis	0.00015	0.000765	CcSEcCtD
Losartan—Vomiting—Mitoxantrone—multiple sclerosis	0.00015	0.000764	CcSEcCtD
Losartan—Rash—Mitoxantrone—multiple sclerosis	0.000149	0.000758	CcSEcCtD
Losartan—Dermatitis—Mitoxantrone—multiple sclerosis	0.000149	0.000757	CcSEcCtD
Losartan—Headache—Mitoxantrone—multiple sclerosis	0.000148	0.000753	CcSEcCtD
Losartan—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000147	0.00075	CcSEcCtD
Losartan—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000147	0.00075	CcSEcCtD
Losartan—Arthralgia—Prednisone—multiple sclerosis	0.000147	0.000748	CcSEcCtD
Losartan—Myalgia—Prednisone—multiple sclerosis	0.000147	0.000748	CcSEcCtD
Losartan—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000147	0.000747	CcSEcCtD
Losartan—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000147	0.000746	CcSEcCtD
Losartan—Anxiety—Prednisone—multiple sclerosis	0.000146	0.000745	CcSEcCtD
Losartan—Alopecia—Methotrexate—multiple sclerosis	0.000146	0.000745	CcSEcCtD
Losartan—Insomnia—Betamethasone—multiple sclerosis	0.000146	0.000744	CcSEcCtD
Losartan—Insomnia—Dexamethasone—multiple sclerosis	0.000146	0.000744	CcSEcCtD
Losartan—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000145	0.00074	CcSEcCtD
Losartan—Paraesthesia—Dexamethasone—multiple sclerosis	0.000145	0.000739	CcSEcCtD
Losartan—Paraesthesia—Betamethasone—multiple sclerosis	0.000145	0.000739	CcSEcCtD
Losartan—Discomfort—Prednisone—multiple sclerosis	0.000145	0.000739	CcSEcCtD
Losartan—Erythema—Methotrexate—multiple sclerosis	0.000144	0.000734	CcSEcCtD
Losartan—Hypersensitivity—Prednisolone—multiple sclerosis	0.000143	0.000727	CcSEcCtD
Losartan—Dyspepsia—Dexamethasone—multiple sclerosis	0.000142	0.000724	CcSEcCtD
Losartan—Dyspepsia—Betamethasone—multiple sclerosis	0.000142	0.000724	CcSEcCtD
Losartan—Urticaria—Triamcinolone—multiple sclerosis	0.000142	0.00072	CcSEcCtD
Losartan—Urticaria—Methylprednisolone—multiple sclerosis	0.000141	0.000719	CcSEcCtD
Losartan—Dysgeusia—Methotrexate—multiple sclerosis	0.000141	0.000719	CcSEcCtD
Losartan—Body temperature increased—Triamcinolone—multiple sclerosis	0.000141	0.000717	CcSEcCtD
Losartan—Oedema—Prednisone—multiple sclerosis	0.000141	0.000717	CcSEcCtD
Losartan—Anaphylactic shock—Prednisone—multiple sclerosis	0.000141	0.000717	CcSEcCtD
Losartan—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000141	0.000715	CcSEcCtD
Losartan—Decreased appetite—Betamethasone—multiple sclerosis	0.000141	0.000715	CcSEcCtD
Losartan—Decreased appetite—Dexamethasone—multiple sclerosis	0.000141	0.000715	CcSEcCtD
Losartan—Nausea—Mitoxantrone—multiple sclerosis	0.00014	0.000714	CcSEcCtD
Losartan—Infection—Prednisone—multiple sclerosis	0.00014	0.000712	CcSEcCtD
Losartan—Back pain—Methotrexate—multiple sclerosis	0.00014	0.00071	CcSEcCtD
Losartan—Fatigue—Betamethasone—multiple sclerosis	0.000139	0.000709	CcSEcCtD
Losartan—Fatigue—Dexamethasone—multiple sclerosis	0.000139	0.000709	CcSEcCtD
Losartan—Shock—Prednisone—multiple sclerosis	0.000139	0.000705	CcSEcCtD
Losartan—Pain—Betamethasone—multiple sclerosis	0.000138	0.000704	CcSEcCtD
Losartan—Pain—Dexamethasone—multiple sclerosis	0.000138	0.000704	CcSEcCtD
Losartan—Nervous system disorder—Prednisone—multiple sclerosis	0.000138	0.000703	CcSEcCtD
Losartan—Tachycardia—Prednisone—multiple sclerosis	0.000137	0.000699	CcSEcCtD
Losartan—Hyperhidrosis—Prednisone—multiple sclerosis	0.000136	0.000693	CcSEcCtD
Losartan—Vision blurred—Methotrexate—multiple sclerosis	0.000136	0.000692	CcSEcCtD
Losartan—Anorexia—Prednisone—multiple sclerosis	0.000134	0.000683	CcSEcCtD
Losartan—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000134	0.000681	CcSEcCtD
Losartan—Anaemia—Methotrexate—multiple sclerosis	0.000133	0.000678	CcSEcCtD
Losartan—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000133	0.000678	CcSEcCtD
Losartan—Feeling abnormal—Betamethasone—multiple sclerosis	0.000133	0.000678	CcSEcCtD
Losartan—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000132	0.000673	CcSEcCtD
Losartan—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000132	0.000673	CcSEcCtD
Losartan—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000131	0.000668	CcSEcCtD
Losartan—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000131	0.000667	CcSEcCtD
Losartan—Malaise—Methotrexate—multiple sclerosis	0.00013	0.000662	CcSEcCtD
Losartan—Vertigo—Methotrexate—multiple sclerosis	0.00013	0.000659	CcSEcCtD
Losartan—Leukopenia—Methotrexate—multiple sclerosis	0.000129	0.000657	CcSEcCtD
Losartan—Urticaria—Dexamethasone—multiple sclerosis	0.000129	0.000654	CcSEcCtD
Losartan—Urticaria—Betamethasone—multiple sclerosis	0.000129	0.000654	CcSEcCtD
Losartan—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000128	0.000653	CcSEcCtD
Losartan—Dizziness—Prednisolone—multiple sclerosis	0.000128	0.000652	CcSEcCtD
Losartan—Asthenia—Triamcinolone—multiple sclerosis	0.000128	0.000651	CcSEcCtD
Losartan—Body temperature increased—Dexamethasone—multiple sclerosis	0.000128	0.000651	CcSEcCtD
Losartan—Abdominal pain—Dexamethasone—multiple sclerosis	0.000128	0.000651	CcSEcCtD
Losartan—Abdominal pain—Betamethasone—multiple sclerosis	0.000128	0.000651	CcSEcCtD
Losartan—Body temperature increased—Betamethasone—multiple sclerosis	0.000128	0.000651	CcSEcCtD
Losartan—Asthenia—Methylprednisolone—multiple sclerosis	0.000128	0.000649	CcSEcCtD
Losartan—Insomnia—Prednisone—multiple sclerosis	0.000127	0.000648	CcSEcCtD
Losartan—Paraesthesia—Prednisone—multiple sclerosis	0.000126	0.000643	CcSEcCtD
Losartan—Pruritus—Triamcinolone—multiple sclerosis	0.000126	0.000642	CcSEcCtD
Losartan—Cough—Methotrexate—multiple sclerosis	0.000126	0.00064	CcSEcCtD
Losartan—Pruritus—Methylprednisolone—multiple sclerosis	0.000126	0.00064	CcSEcCtD
Losartan—Dyspepsia—Prednisone—multiple sclerosis	0.000124	0.000631	CcSEcCtD
Losartan—Myalgia—Methotrexate—multiple sclerosis	0.000123	0.000625	CcSEcCtD
Losartan—Arthralgia—Methotrexate—multiple sclerosis	0.000123	0.000625	CcSEcCtD
Losartan—Chest pain—Methotrexate—multiple sclerosis	0.000123	0.000625	CcSEcCtD
Losartan—Decreased appetite—Prednisone—multiple sclerosis	0.000122	0.000623	CcSEcCtD
Losartan—Rash—Prednisolone—multiple sclerosis	0.000122	0.000622	CcSEcCtD
Losartan—Dermatitis—Prednisolone—multiple sclerosis	0.000122	0.000621	CcSEcCtD
Losartan—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000122	0.000619	CcSEcCtD
Losartan—Fatigue—Prednisone—multiple sclerosis	0.000121	0.000618	CcSEcCtD
Losartan—Headache—Prednisolone—multiple sclerosis	0.000121	0.000618	CcSEcCtD
Losartan—Discomfort—Methotrexate—multiple sclerosis	0.000121	0.000617	CcSEcCtD
Losartan—Constipation—Prednisone—multiple sclerosis	0.00012	0.000613	CcSEcCtD
Losartan—Confusional state—Methotrexate—multiple sclerosis	0.000119	0.000604	CcSEcCtD
Losartan—Dizziness—Triamcinolone—multiple sclerosis	0.000118	0.0006	CcSEcCtD
Losartan—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000118	0.000599	CcSEcCtD
Losartan—Dizziness—Methylprednisolone—multiple sclerosis	0.000118	0.000598	CcSEcCtD
Losartan—Infection—Methotrexate—multiple sclerosis	0.000117	0.000595	CcSEcCtD
Losartan—Feeling abnormal—Prednisone—multiple sclerosis	0.000116	0.000591	CcSEcCtD
Losartan—Asthenia—Betamethasone—multiple sclerosis	0.000116	0.00059	CcSEcCtD
Losartan—Asthenia—Dexamethasone—multiple sclerosis	0.000116	0.00059	CcSEcCtD
Losartan—Nervous system disorder—Methotrexate—multiple sclerosis	0.000115	0.000587	CcSEcCtD
Losartan—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000115	0.000586	CcSEcCtD
Losartan—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000115	0.000586	CcSEcCtD
Losartan—Nausea—Prednisolone—multiple sclerosis	0.000115	0.000586	CcSEcCtD
Losartan—Pruritus—Betamethasone—multiple sclerosis	0.000114	0.000582	CcSEcCtD
Losartan—Pruritus—Dexamethasone—multiple sclerosis	0.000114	0.000582	CcSEcCtD
Losartan—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000114	0.000579	CcSEcCtD
Losartan—Vomiting—Triamcinolone—multiple sclerosis	0.000113	0.000577	CcSEcCtD
Losartan—Vomiting—Methylprednisolone—multiple sclerosis	0.000113	0.000575	CcSEcCtD
Losartan—Rash—Triamcinolone—multiple sclerosis	0.000112	0.000572	CcSEcCtD
Losartan—Dermatitis—Triamcinolone—multiple sclerosis	0.000112	0.000571	CcSEcCtD
Losartan—Anorexia—Methotrexate—multiple sclerosis	0.000112	0.000571	CcSEcCtD
Losartan—Rash—Methylprednisolone—multiple sclerosis	0.000112	0.000571	CcSEcCtD
Losartan—Dermatitis—Methylprednisolone—multiple sclerosis	0.000112	0.00057	CcSEcCtD
Losartan—Urticaria—Prednisone—multiple sclerosis	0.000112	0.000569	CcSEcCtD
Losartan—Headache—Triamcinolone—multiple sclerosis	0.000112	0.000568	CcSEcCtD
Losartan—Headache—Methylprednisolone—multiple sclerosis	0.000111	0.000567	CcSEcCtD
Losartan—Body temperature increased—Prednisone—multiple sclerosis	0.000111	0.000567	CcSEcCtD
Losartan—Abdominal pain—Prednisone—multiple sclerosis	0.000111	0.000567	CcSEcCtD
Losartan—Diarrhoea—Dexamethasone—multiple sclerosis	0.000111	0.000563	CcSEcCtD
Losartan—Diarrhoea—Betamethasone—multiple sclerosis	0.000111	0.000563	CcSEcCtD
Losartan—Hypotension—Methotrexate—multiple sclerosis	0.00011	0.00056	CcSEcCtD
Losartan—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000107	0.000546	CcSEcCtD
Losartan—Dizziness—Betamethasone—multiple sclerosis	0.000107	0.000544	CcSEcCtD
Losartan—Dizziness—Dexamethasone—multiple sclerosis	0.000107	0.000544	CcSEcCtD
Losartan—Insomnia—Methotrexate—multiple sclerosis	0.000106	0.000542	CcSEcCtD
Losartan—Nausea—Triamcinolone—multiple sclerosis	0.000106	0.000539	CcSEcCtD
Losartan—Paraesthesia—Methotrexate—multiple sclerosis	0.000106	0.000538	CcSEcCtD
Losartan—Nausea—Methylprednisolone—multiple sclerosis	0.000106	0.000537	CcSEcCtD
Losartan—Dyspnoea—Methotrexate—multiple sclerosis	0.000105	0.000534	CcSEcCtD
Losartan—Somnolence—Methotrexate—multiple sclerosis	0.000105	0.000532	CcSEcCtD
Losartan—Hypersensitivity—Prednisone—multiple sclerosis	0.000104	0.000528	CcSEcCtD
Losartan—Dyspepsia—Methotrexate—multiple sclerosis	0.000104	0.000527	CcSEcCtD
Losartan—Vomiting—Dexamethasone—multiple sclerosis	0.000103	0.000523	CcSEcCtD
Losartan—Vomiting—Betamethasone—multiple sclerosis	0.000103	0.000523	CcSEcCtD
Losartan—Decreased appetite—Methotrexate—multiple sclerosis	0.000102	0.000521	CcSEcCtD
Losartan—Rash—Betamethasone—multiple sclerosis	0.000102	0.000519	CcSEcCtD
Losartan—Rash—Dexamethasone—multiple sclerosis	0.000102	0.000519	CcSEcCtD
Losartan—Dermatitis—Dexamethasone—multiple sclerosis	0.000102	0.000518	CcSEcCtD
Losartan—Dermatitis—Betamethasone—multiple sclerosis	0.000102	0.000518	CcSEcCtD
Losartan—Fatigue—Methotrexate—multiple sclerosis	0.000102	0.000516	CcSEcCtD
Losartan—Headache—Betamethasone—multiple sclerosis	0.000101	0.000516	CcSEcCtD
Losartan—Headache—Dexamethasone—multiple sclerosis	0.000101	0.000516	CcSEcCtD
Losartan—Asthenia—Prednisone—multiple sclerosis	0.000101	0.000514	CcSEcCtD
Losartan—Pain—Methotrexate—multiple sclerosis	0.000101	0.000512	CcSEcCtD
Losartan—Pruritus—Prednisone—multiple sclerosis	9.97e-05	0.000507	CcSEcCtD
Losartan—Feeling abnormal—Methotrexate—multiple sclerosis	9.7e-05	0.000494	CcSEcCtD
Losartan—Diarrhoea—Prednisone—multiple sclerosis	9.64e-05	0.00049	CcSEcCtD
Losartan—Gastrointestinal pain—Methotrexate—multiple sclerosis	9.63e-05	0.00049	CcSEcCtD
Losartan—Nausea—Dexamethasone—multiple sclerosis	9.61e-05	0.000489	CcSEcCtD
Losartan—Nausea—Betamethasone—multiple sclerosis	9.61e-05	0.000489	CcSEcCtD
Losartan—Urticaria—Methotrexate—multiple sclerosis	9.35e-05	0.000476	CcSEcCtD
Losartan—Dizziness—Prednisone—multiple sclerosis	9.32e-05	0.000474	CcSEcCtD
Losartan—Abdominal pain—Methotrexate—multiple sclerosis	9.31e-05	0.000473	CcSEcCtD
Losartan—Body temperature increased—Methotrexate—multiple sclerosis	9.31e-05	0.000473	CcSEcCtD
Losartan—Vomiting—Prednisone—multiple sclerosis	8.96e-05	0.000456	CcSEcCtD
Losartan—Rash—Prednisone—multiple sclerosis	8.88e-05	0.000452	CcSEcCtD
Losartan—Dermatitis—Prednisone—multiple sclerosis	8.87e-05	0.000451	CcSEcCtD
Losartan—Headache—Prednisone—multiple sclerosis	8.83e-05	0.000449	CcSEcCtD
Losartan—Hypersensitivity—Methotrexate—multiple sclerosis	8.67e-05	0.000441	CcSEcCtD
Losartan—Asthenia—Methotrexate—multiple sclerosis	8.45e-05	0.00043	CcSEcCtD
Losartan—Nausea—Prednisone—multiple sclerosis	8.37e-05	0.000426	CcSEcCtD
Losartan—Pruritus—Methotrexate—multiple sclerosis	8.33e-05	0.000424	CcSEcCtD
Losartan—Diarrhoea—Methotrexate—multiple sclerosis	8.06e-05	0.00041	CcSEcCtD
Losartan—Dizziness—Methotrexate—multiple sclerosis	7.79e-05	0.000396	CcSEcCtD
Losartan—Vomiting—Methotrexate—multiple sclerosis	7.49e-05	0.000381	CcSEcCtD
Losartan—Rash—Methotrexate—multiple sclerosis	7.42e-05	0.000378	CcSEcCtD
Losartan—Dermatitis—Methotrexate—multiple sclerosis	7.42e-05	0.000377	CcSEcCtD
Losartan—Headache—Methotrexate—multiple sclerosis	7.38e-05	0.000375	CcSEcCtD
Losartan—Nausea—Methotrexate—multiple sclerosis	6.99e-05	0.000356	CcSEcCtD
Losartan—AGTR1—Signaling by GPCR—PTGER4—multiple sclerosis	5.42e-05	0.000511	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RGS1—multiple sclerosis	5.38e-05	0.000508	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—RRM1—multiple sclerosis	5.33e-05	0.000502	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	5.29e-05	0.000499	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	5.28e-05	0.000498	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	5.27e-05	0.000497	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—POMC—multiple sclerosis	5.27e-05	0.000497	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CXCR3—multiple sclerosis	5.23e-05	0.000494	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CNR1—multiple sclerosis	5.18e-05	0.000488	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—CCL2—multiple sclerosis	5.16e-05	0.000486	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CYP24A1—multiple sclerosis	5.15e-05	0.000486	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CYP27B1—multiple sclerosis	5.15e-05	0.000486	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—GPR65—multiple sclerosis	5.1e-05	0.000482	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCR2—multiple sclerosis	5.09e-05	0.00048	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	5.05e-05	0.000477	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	5.05e-05	0.000476	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	5.01e-05	0.000473	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—POMC—multiple sclerosis	5e-05	0.000471	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.96e-05	0.000468	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.96e-05	0.000468	CbGpPWpGaD
Losartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	4.91e-05	0.000463	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—CCL2—multiple sclerosis	4.89e-05	0.000461	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	4.82e-05	0.000455	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—RRM1—multiple sclerosis	4.81e-05	0.000453	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	4.72e-05	0.000445	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	4.72e-05	0.000445	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GPC5—multiple sclerosis	4.71e-05	0.000445	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CNR1—multiple sclerosis	4.7e-05	0.000443	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.7e-05	0.000443	CbGpPWpGaD
Losartan—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.67e-05	0.000441	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCL13—multiple sclerosis	4.67e-05	0.00044	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCR1—multiple sclerosis	4.67e-05	0.00044	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CXCL10—multiple sclerosis	4.66e-05	0.00044	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.62e-05	0.000435	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	4.5e-05	0.000425	CbGpPWpGaD
Losartan—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.47e-05	0.000422	CbGpPWpGaD
Losartan—UGT1A1—NRF2 pathway—TGFB1—multiple sclerosis	4.46e-05	0.00042	CbGpPWpGaD
Losartan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.45e-05	0.00042	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SRM—multiple sclerosis	4.45e-05	0.000419	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GPC5—multiple sclerosis	4.32e-05	0.000407	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	4.3e-05	0.000406	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL2—multiple sclerosis	4.28e-05	0.000404	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.24e-05	0.0004	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.24e-05	0.0004	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.24e-05	0.0004	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CXCL10—multiple sclerosis	4.23e-05	0.000399	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.13e-05	0.00039	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.12e-05	0.000389	CbGpPWpGaD
Losartan—CYP3A5—Biological oxidations—POMC—multiple sclerosis	4.12e-05	0.000389	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.11e-05	0.000388	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—TNF—multiple sclerosis	4.11e-05	0.000388	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.11e-05	0.000388	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	4.08e-05	0.000385	CbGpPWpGaD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.07e-05	0.000384	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.03e-05	0.00038	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CCL5—multiple sclerosis	4.01e-05	0.000378	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—RRM1—multiple sclerosis	3.91e-05	0.000368	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SRM—multiple sclerosis	3.85e-05	0.000363	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.85e-05	0.000363	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	3.84e-05	0.000362	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3.84e-05	0.000362	CbGpPWpGaD
Losartan—ALB—Metabolism—SRM—multiple sclerosis	3.83e-05	0.000361	CbGpPWpGaD
Losartan—ALB—Hemostasis—SELE—multiple sclerosis	3.82e-05	0.000361	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—TGFB1—multiple sclerosis	3.78e-05	0.000356	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.71e-05	0.00035	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	3.66e-05	0.000345	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCL5—multiple sclerosis	3.64e-05	0.000344	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.63e-05	0.000342	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CCR5—multiple sclerosis	3.61e-05	0.000341	CbGpPWpGaD
Losartan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.61e-05	0.00034	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	3.6e-05	0.000339	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—RRM1—multiple sclerosis	3.58e-05	0.000338	CbGpPWpGaD
Losartan—CYP2C8—Biological oxidations—POMC—multiple sclerosis	3.57e-05	0.000337	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—IL2RA—multiple sclerosis	3.56e-05	0.000336	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.55e-05	0.000335	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SRM—multiple sclerosis	3.44e-05	0.000324	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SRM—multiple sclerosis	3.36e-05	0.000317	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.34e-05	0.000315	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCL3—multiple sclerosis	3.33e-05	0.000314	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—IL6—multiple sclerosis	3.32e-05	0.000313	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCR5—multiple sclerosis	3.28e-05	0.00031	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.28e-05	0.00031	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	3.27e-05	0.000308	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.25e-05	0.000307	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—BCHE—multiple sclerosis	3.25e-05	0.000306	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.24e-05	0.000305	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL2RA—multiple sclerosis	3.23e-05	0.000305	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PTGER4—multiple sclerosis	3.2e-05	0.000302	CbGpPWpGaD
Losartan—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.19e-05	0.000301	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PGR—multiple sclerosis	3.15e-05	0.000297	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SRM—multiple sclerosis	3.13e-05	0.000296	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	3.13e-05	0.000296	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	3.13e-05	0.000296	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.12e-05	0.000294	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCR3—multiple sclerosis	3.09e-05	0.000292	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.08e-05	0.00029	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CD28—multiple sclerosis	3.06e-05	0.000289	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—BCHE—multiple sclerosis	3.06e-05	0.000289	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCR2—multiple sclerosis	3.01e-05	0.000284	CbGpPWpGaD
Losartan—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.9e-05	0.000274	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.87e-05	0.000271	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.87e-05	0.00027	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—POMC—multiple sclerosis	2.82e-05	0.000266	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.78e-05	0.000262	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CNR1—multiple sclerosis	2.78e-05	0.000262	CbGpPWpGaD
Losartan—ALB—Hemostasis—ITGA4—multiple sclerosis	2.76e-05	0.000261	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—BCHE—multiple sclerosis	2.76e-05	0.00026	CbGpPWpGaD
Losartan—ALB—Hemostasis—IFNB1—multiple sclerosis	2.74e-05	0.000259	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.71e-05	0.000256	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.71e-05	0.000256	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP27B1—multiple sclerosis	2.7e-05	0.000255	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP24A1—multiple sclerosis	2.7e-05	0.000255	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SRM—multiple sclerosis	2.68e-05	0.000253	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.65e-05	0.00025	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.64e-05	0.000249	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	2.64e-05	0.000249	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—POMC—multiple sclerosis	2.56e-05	0.000242	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCL2—multiple sclerosis	2.51e-05	0.000237	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCL10—multiple sclerosis	2.5e-05	0.000236	CbGpPWpGaD
Losartan—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.48e-05	0.000234	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.48e-05	0.000234	CbGpPWpGaD
Losartan—ALB—Metabolism—GPC5—multiple sclerosis	2.47e-05	0.000233	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.42e-05	0.000228	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.42e-05	0.000228	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.39e-05	0.000225	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.37e-05	0.000224	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.37e-05	0.000223	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.36e-05	0.000223	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.36e-05	0.000223	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—TYK2—multiple sclerosis	2.28e-05	0.000215	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.27e-05	0.000214	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—BCHE—multiple sclerosis	2.24e-05	0.000212	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.22e-05	0.000209	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.21e-05	0.000208	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.21e-05	0.000208	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CD86—multiple sclerosis	2.19e-05	0.000206	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.17e-05	0.000205	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GPC5—multiple sclerosis	2.16e-05	0.000204	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.16e-05	0.000204	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCL5—multiple sclerosis	2.15e-05	0.000203	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	2.15e-05	0.000203	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—IL2—multiple sclerosis	2.09e-05	0.000197	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.07e-05	0.000195	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SRM—multiple sclerosis	2.07e-05	0.000195	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.06e-05	0.000194	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—BCHE—multiple sclerosis	2.06e-05	0.000194	CbGpPWpGaD
Losartan—ALB—Metabolism—RRM1—multiple sclerosis	2.04e-05	0.000193	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.02e-05	0.000191	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SPP1—multiple sclerosis	1.99e-05	0.000188	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—APOE—multiple sclerosis	1.95e-05	0.000184	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCR5—multiple sclerosis	1.94e-05	0.000183	CbGpPWpGaD
Losartan—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.92e-05	0.000181	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL2RA—multiple sclerosis	1.91e-05	0.00018	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL2—multiple sclerosis	1.9e-05	0.000179	CbGpPWpGaD
Losartan—ALB—Hemostasis—IL2RA—multiple sclerosis	1.89e-05	0.000178	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.89e-05	0.000178	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.89e-05	0.000178	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.84e-05	0.000174	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—APOE—multiple sclerosis	1.84e-05	0.000174	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.84e-05	0.000173	CbGpPWpGaD
Losartan—ABCB1—Metabolism—RRM1—multiple sclerosis	1.79e-05	0.000169	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—APOE—multiple sclerosis	1.76e-05	0.000166	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.73e-05	0.000163	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—POMC—multiple sclerosis	1.68e-05	0.000158	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.67e-05	0.000158	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.67e-05	0.000158	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—APOE—multiple sclerosis	1.66e-05	0.000157	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.65e-05	0.000156	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.65e-05	0.000156	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.64e-05	0.000155	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.62e-05	0.000153	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.6e-05	0.000151	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CD80—multiple sclerosis	1.59e-05	0.00015	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.59e-05	0.00015	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—POMC—multiple sclerosis	1.58e-05	0.000149	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.54e-05	0.000145	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—ALB—multiple sclerosis	1.53e-05	0.000144	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—POMC—multiple sclerosis	1.51e-05	0.000143	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCL2—multiple sclerosis	1.48e-05	0.00014	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.46e-05	0.000137	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.46e-05	0.000137	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—MAPK1—multiple sclerosis	1.45e-05	0.000137	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—ALB—multiple sclerosis	1.44e-05	0.000136	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.43e-05	0.000135	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—POMC—multiple sclerosis	1.43e-05	0.000135	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.42e-05	0.000134	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.37e-05	0.000129	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.36e-05	0.000129	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.36e-05	0.000129	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—APOE—multiple sclerosis	1.35e-05	0.000127	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TYK2—multiple sclerosis	1.35e-05	0.000127	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.33e-05	0.000126	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ALB—multiple sclerosis	1.3e-05	0.000123	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.3e-05	0.000122	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.25e-05	0.000118	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—APOE—multiple sclerosis	1.24e-05	0.000117	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.22e-05	0.000115	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.18e-05	0.000111	CbGpPWpGaD
Losartan—ALB—Metabolism—BCHE—multiple sclerosis	1.17e-05	0.000111	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—POMC—multiple sclerosis	1.16e-05	0.000109	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL2—multiple sclerosis	1.12e-05	0.000106	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.12e-05	0.000105	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.12e-05	0.000105	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL6—multiple sclerosis	1.11e-05	0.000105	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.11e-05	0.000105	CbGpPWpGaD
Losartan—ALB—Hemostasis—IL2—multiple sclerosis	1.11e-05	0.000104	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.1e-05	0.000104	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—POMC—multiple sclerosis	1.06e-05	0.0001	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MMP9—multiple sclerosis	1.06e-05	0.0001	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ALB—multiple sclerosis	1.06e-05	9.97e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.05e-05	9.95e-05	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.04e-05	9.76e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—BCHE—multiple sclerosis	1.03e-05	9.71e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.02e-05	9.59e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ALB—multiple sclerosis	9.68e-06	9.14e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—BCHE—multiple sclerosis	9.61e-06	9.07e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.53e-06	8.99e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—STAT3—multiple sclerosis	9.42e-06	8.89e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MYC—multiple sclerosis	8.76e-06	8.26e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TGFB1—multiple sclerosis	8.74e-06	8.24e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.69e-06	8.2e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—TGFB1—multiple sclerosis	8.63e-06	8.14e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK1—multiple sclerosis	8.57e-06	8.08e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—MAPK1—multiple sclerosis	8.46e-06	7.99e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—BCHE—multiple sclerosis	8.21e-06	7.75e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—APOE—multiple sclerosis	8.2e-06	7.74e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—APOE—multiple sclerosis	7.1e-06	6.7e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—APOE—multiple sclerosis	7.06e-06	6.66e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—POMC—multiple sclerosis	7.05e-06	6.65e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL6—multiple sclerosis	6.58e-06	6.21e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ALB—multiple sclerosis	6.42e-06	6.06e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—APOE—multiple sclerosis	6.34e-06	5.98e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.34e-06	5.98e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—APOE—multiple sclerosis	6.19e-06	5.84e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—POMC—multiple sclerosis	6.1e-06	5.76e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—POMC—multiple sclerosis	6.07e-06	5.73e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—APOE—multiple sclerosis	5.78e-06	5.46e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ALB—multiple sclerosis	5.56e-06	5.25e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—POMC—multiple sclerosis	5.45e-06	5.14e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—POMC—multiple sclerosis	5.32e-06	5.02e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—POMC—multiple sclerosis	4.97e-06	4.69e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ALB—multiple sclerosis	4.97e-06	4.69e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—APOE—multiple sclerosis	4.94e-06	4.66e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ALB—multiple sclerosis	4.85e-06	4.57e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ALB—multiple sclerosis	4.53e-06	4.27e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—POMC—multiple sclerosis	4.24e-06	4e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALB—multiple sclerosis	3.87e-06	3.65e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—APOE—multiple sclerosis	3.81e-06	3.6e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—POMC—multiple sclerosis	3.28e-06	3.09e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALB—multiple sclerosis	2.99e-06	2.82e-05	CbGpPWpGaD
